Literature DB >> 9760130

Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats.

C V Borlongan1, S Saporta, S G Poulos, A Othberg, P R Sanberg.   

Abstract

We recently reported behavioral improvements following intrastriatal transplantation of cryopreserved cultured human neuroteratocarcinoma-derived cells (hNT neurons) in rats with cerebral ischemia induced by occlusion of the middle cerebral artery. In the present study, the viability and survival of hNT neurons were evaluated immediately prior to the transplantation surgery and at 3 months post-transplantation in ischemic rats. Cryopreserved hNT neurons were routinely thawed, and trypan blue exclusion viability counts revealed 52-95% viable hNT neurons before transplantation. Monthly behavioral tests, starting at 1 month and extending to 3 months post-transplantation, revealed that ischemic animals that were intrastriatally transplanted with hNT neurons (approximately 40000) and treated with an immunosuppressive drug displayed normalization of asymmetrical motor behavior compared with ischemic animals that received medium alone. Within-subject comparisons of cell viability and subsequent behavioral changes revealed that a high cell viability just prior to transplantation surgery correlated highly with a robust and sustained functional improvement in the transplant recipient. Furthermore, histological analysis of grafted brains revealed a positive correlation between number of surviving hNT neurons and degree of functional recovery. In concert with similar reports on fetal tissue transplantation, we conclude that high cell viability is an important criterion for successful transplantation of cryopreserved neurons derived from cell lines to enhance graft-induced functional effects.

Entities:  

Mesh:

Year:  1998        PMID: 9760130     DOI: 10.1097/00001756-199808240-00028

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

Review 1.  Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier.

Authors:  Gabriel S Gonzales-Portillo; Paul R Sanberg; Max Franzblau; Chiara Gonzales-Portillo; Theo Diamandis; Meaghan Staples; Cyndy D Sanberg; Cesar V Borlongan
Journal:  Cell Transplant       Date:  2014-01-29       Impact factor: 4.064

Review 2.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

3.  Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation.

Authors:  Peter T Nelson; Douglas Kondziolka; Lawrence Wechsler; Steven Goldstein; James Gebel; Sharon DeCesare; Elaine M Elder; Paul J Zhang; Alan Jacobs; Michael McGrogan; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

4.  Drug-like delivery methods of stem cells as biologics for stroke.

Authors:  Julian P Tuazon; Vanessa Castelli; Cesar V Borlongan
Journal:  Expert Opin Drug Deliv       Date:  2019-08-05       Impact factor: 6.648

Review 5.  Cell Therapy for Stroke: A Mechanistic Analysis.

Authors:  Ben Jiahe Gu; David K Kung; Han-Chiao Isaac Chen
Journal:  Neurosurgery       Date:  2021-03-15       Impact factor: 4.654

Review 6.  Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction.

Authors:  Justin Cho; You Jeong Park; Bella Gonzales-Portillo; Madeline Saft; Blaise Cozene; Nadia Sadanandan; Cesar V Borlongan
Journal:  CNS Neurosci Ther       Date:  2021-01-19       Impact factor: 5.243

7.  Behavioral outcome measures used for human neural stem cell transplantation in rat stroke models.

Authors:  Matthew B Jensen; Dong Y Han; Abdullah Al Sawaf; Rajeev Krishnaney-Davison
Journal:  Neurol Int       Date:  2011-09-22

8.  Colloids as mobile substrates for the implantation and integration of differentiated neurons into the mammalian brain.

Authors:  Dennis Jgamadze; Jamie Bergen; Daniel Stone; Jae-Hyung Jang; David V Schaffer; Ehud Y Isacoff; Sophie Pautot
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

9.  Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression.

Authors:  J Gao; X-Y Kang; S Sun; L Li; B-L Zhang; Y-Q Li; D-S Gao
Journal:  Cell Death Dis       Date:  2016-05-05       Impact factor: 8.469

10.  Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro Study.

Authors:  Li-Li Cui; Tuure Kinnunen; Johannes Boltze; Johanna Nystedt; Jukka Jolkkonen
Journal:  Stem Cells Int       Date:  2016-02-28       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.